Oracle Launches Oracle Health Sciences Institute, in Partnership with Sun Labs
Oracle today announced the creation of the
OHSI will work in tandem with academic research centers, focusing on a targeted set of research areas fundamental to the R&D and health care delivery challenges facing health sciences organizations today. OHSI’s research priorities currently include: artificial intelligence and semantic technology; genomic, genetic and phenotypic data analysis; data mining to support optimization of clinical trials; and predictive algorithms and other technology to advance patient safety and provide advanced decision support at the point of care.
“IT innovation is essential to accelerating the discovery, development and delivery of next-generation treatments, therapies and health care service innovations,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. “Oracle created the Oracle Health Sciences Institute, in partnership with Sun Labs, to advance this objective. By combining Oracle and Sun Labs’ scientific talent and resources with collaborators worldwide, OHSI is positioned to help design IT innovations that will aid in improving patient care around the world.”
Academic institutions interested in collaborating with OHSI in these focus areas should contact OHSI representatives at
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025